Researchers: Comorbidities raise MERS mortality risks

07/26/2013 | Medscape (free registration)

Middle East respiratory syndrome is clinically different than severe acute respiratory syndrome and can lead to significant mortality rates in hospital patients who have comorbidities, according to a study in the Lancet Infectious Diseases. Researchers from Saudi Arabia said MERS can progress to respiratory failure five days earlier than SARS, although SARS appears to be more infectious in health care settings.

View Full Article in:

Medscape (free registration)

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
European Sales Manager
SentreHEART, Inc.
Germany, Benelux, UK
REG AFFAIRS PROJ MGR - 1400000A7F
Abbott
San Jose, CA
SPECIALIST II SYSTEMS INTEGRATION - 140000033P
Abbott
Dallas, TX
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD